R. Ellis

Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine.

I. Grant, Heather Bentley, T. Yaksh, 2006, Clinical chemistry.

Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial

P. Ferenci, S. Samira, Y. Ilan, 2015, Journal of viral hepatitis.

Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial Network’s HI-Light Vitiligo Trial Team

A. Montgomery, T. Sach, J. Ingram, 2020 .

Randomised controlled trial of topical corticosteroid and home-based narrowband UVB for active and limited vitiligo – results of the HI-Light Vitiligo trial Short title: Home-based narrowband UVB and topical steroid for vitiligo

A. Montgomery, K. Thomas, A. Bewley, 2020 .

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

I. Turgeman, S. Samira, Y. Ilan, 2015, Journal of Clinical Immunology.

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

I. Turgeman, S. Samira, Y. Ilan, 2015, Journal of Clinical Immunology.